Christina Ann Wicker

Christina Ann Wicker

Auto-generated profile, based on publicly available information

Christina Ann Wicker

Department of Radiation Oncology, University of Cincinnati, Cincinnati, OH, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
TSTimothy L. Scott
Timothy L. Scott
SRSuganya Rangaswamy
Suganya Rangaswamy
CWChristina A. Wicker
Christina A. Wicker
TITadahide Izumi
Tadahide Izumi
Significance: Reactive oxygen species (ROS) are generated by exogenous and environmental genotoxins, but also arise from mitochondria as byproducts of respiration in the body. ROS generate DNA damage of which pathological consequence, including cancer is well established. Research efforts are intense to understand the mechanism of DNA base excision repair, the primary mechanism to protect cells from genotoxicity caused by ROS. Recent Advances: In addition to the notion that oxidative DNA damage causes transformation of cells, recent studies have revealed how the mitochondrial deficiencies and ROS generation alter cell growth during the cancer transformation. Critical Issues: The emphasis of this review is to highlight the importance of the cellular response to oxidative DNA damage during carcinogenesis. Oxidative DNA damage, including 7,8-dihydro-8-oxoguanine, play an important role during the cellular transformation. It is also becoming apparent that the unusual activity and subcellular distribution of apurinic/apyrimidinic endonuclease 1, an essential DNA repair factor/redox sensor, affect cancer malignancy by increasing cellular resistance to oxidative stress and by positively influencing cell proliferation. Future Directions: Technological advancement in cancer cell biology and genetics has enabled us to monitor the detailed DNA repair activities in the microenvironment. Precise understanding of the intracellular activities of DNA repair proteins for oxidative DNA damage should provide help in understanding how mitochondria, ROS, DNA damage, and repair influence cancer transformation. Antioxid. Redox Signal. 20, 708–726.

1 April 2021 in Cancer Letters
Verified
Journal Article
Closed access
CWChristina A. Wicker
Christina A. Wicker
BHBrian G. Hunt
Brian G. Hunt
SKSunil Krishnan
Sunil Krishnan
KAKathryn Aziz
Kathryn Aziz
SPShobha Parajuli
Shobha Parajuli
VTVinita Takiar
Vinita Takiar

5 May 2016 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
TSTimothy L. Scott
Timothy L. Scott
CWChristina A. Wicker
Christina A. Wicker
RSRangaswamy Suganya
Rangaswamy Suganya
BDBithika Dhar
Bithika Dhar
TPThomas Pittman
Thomas Pittman
TITadahide Izumi
Tadahide Izumi

27 April 2020 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
BHBrian G. Hunt
Brian G. Hunt
CWChristina A. Wicker
Christina A. Wicker
JBJennifer R. Bourn
Jennifer R. Bourn
ELElyse E. Lower
Elyse E. Lower
VTVinita Takiar
Vinita Takiar
SWSusan E Waltz
Susan E Waltz

9 September 2020 in Cancers of the Head & Neck
Verified
Journal Article
Open access
PDF file
SKSuchin Khanna
Suchin Khanna
SPSarah Palackdharry
Sarah Palackdharry
LRLogan Roof
Logan Roof
CWChristina A. Wicker
Christina A. Wicker
JMJonathan Mark
Jonathan Mark
TWTrisha M. Wise-Draper
Trisha M. Wise-Draper
Background: Human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCC) has a better prognosis than HNSCC due to other risk factors. However, there is significant heterogeneity within HPV-associated HNSCC and 25% of these patients still do poorly despite receiving aggressive therapy. We currently have no good molecular tools to differentiate and exclude this “high-risk” sub-population and focus on “low-risk” patients for clinical trials. This has been a potential barrier to identifying successful de-escalation treatment strategies in HPV-associated HNSCC. We conducted an analysis of molecular markers with a well-known role in the pathogenesis of HPV-associated HNSCC and hypothesized that these markers could help independently predict recurrence and prognosis in these patients and therefore help identify at the molecular level “low-risk” patients suitable for de-escalation trials. Methods: We analyzed 24 tumor specimens of patients with p16+ HNSCC who underwent definitive resection as primary treatment. Tissue microarray (TMA) was generated from the 24 pathology blocks and immunohistochemistry (IHC) was performed using highly specific antibodies for our chosen biomarkers (PI3K-PTEN, AKT pathway, mTOR, 4EBP1, S6, and pAMPK, ERCC-1). Transcriptome data was also obtained for 7 p16+ HNSCC patients from The Cancer Genome Atlas (TCGA). Data from the TMA and TCGA were analyzed for association of relapse-free survival (RFS) and overall survival (OS) with protein and gene expression of the chosen biomarkers. Results: Increased pAMPK protein activity by IHC and AMPK gene expression by TCGA gene expression data was correlated with improved RFS with a trend towards statistical significance. Conclusions: This data suggests that increased pAMPK activity and expression may portend a better prognosis in HPV-associated HNSCC undergoing primary definitive resection. However, these findings require validation in larger studies.

1 December 2016 in BMC Genomics
Verified
Journal Article
Open access
PDF file
CWChristina A. Wicker
Christina A. Wicker
TITadahide Izumi
Tadahide Izumi
The COP9 signalosome, composed of eight subunits, is implicated in cancer genetics with its deneddylase activity to modulate cellular concentration of oncogenic proteins such as IkB and TGFβ. However, its function in the normal cell physiology remains elusive. Primarily focusing on gene expression data of the normal tissues of the head and neck, the cancer genome atlas (TCGA) database was used to identify groups of genes that were expressed synergistically with the COP9 genes, particularly with the COPS5 (CSN5), which possesses the catalytic activity of COP9. Expressions of seven of the COP9 genes (COPS2, COPS3, COPS4, COPS5, COPS6, COPS7A, and COPS8) were found to be highly synergistic in the normal tissues. In contrast, the tumor tissues decreased the coordinated expression pattern of COP9 genes. Pathway analysis revealed a high coordination of the expression of the COPS5 and the other COP9 genes with mitochondria-related functional pathways, including genes encoding the respiratory chain complex. The results indicate that mRNA expression data for the matched normal tissues available in TCGA are statistically reliable, and are highly useful to assess novel associations of genes with functional pathways in normal physiology as well as in the cancer tissues. This study revealed the significant correlation between the expressions of the COP9 genes and those related to the mitochondrial activity.